TR200201600T2 - Yer-alıma tabi tutulan, yeni, dallı 3-amino-1-fenil-1H-[1,2,4]triazol amino türevleri, bunların hazırlanması için prosesler ve bunları içeren farmasötik kompozisyonlar. - Google Patents

Yer-alıma tabi tutulan, yeni, dallı 3-amino-1-fenil-1H-[1,2,4]triazol amino türevleri, bunların hazırlanması için prosesler ve bunları içeren farmasötik kompozisyonlar.

Info

Publication number
TR200201600T2
TR200201600T2 TR2002/01600T TR200201600T TR200201600T2 TR 200201600 T2 TR200201600 T2 TR 200201600T2 TR 2002/01600 T TR2002/01600 T TR 2002/01600T TR 200201600 T TR200201600 T TR 200201600T TR 200201600 T2 TR200201600 T2 TR 200201600T2
Authority
TR
Turkey
Prior art keywords
alkyl
amino
symbol
phenyl
processes
Prior art date
Application number
TR2002/01600T
Other languages
English (en)
Inventor
Geslin Michel
Gully Danielle
Maffrand Jean-Pierre
Roger Pierre
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of TR200201600T2 publication Critical patent/TR200201600T2/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Mevcut bulus, asagidaki formüle sahip bilesikler ile ilgili olup; bu bilesik içerisinde, özellikle, R1, R2 ve R3 sembollerinin her biri birbirlerinden bagimsiz olarak hidrojen; bir halojen atomu; bir (C1-C5)alkil; bir (C1-C5)alkoksi; bir triflüorometil ya da R sembolü bir (C1-C5)alkil olan bir S-R grubudur; R4 ve R5 sembolleri bir (C1-C5)alkil; 3 ila 5 karbon atomlu bir alkinil; bir (C3-C5)sikloalkil ya da Ra sembolü bir (C1-C3)alkil ve X sembolü O olan bir Ra-X-(C1-C2)alkil grubu; R6 sembolü -CHR7R8 olurken, R7 sembolü, 3-, 4- ve 5-pozisyonlarindan, halojen olan bir ya da daha fazla Z' radikali ile yer-alima tabi tutulabilen bir fenil grubu; bir (C1-C5)alkil; X sembolü O alan bir (C1-C5)alkil-X- ya da (C1-C3)alkil-X-(C1-C2)alkil; bir metilendioksi grubu; ve R8 sembolü bir (C1-C6)alkil; bir (C3-C5)sikloalkil(C1-C3)alkil; ya da X sembolü O olan bir (C1-C3)alkil-X-(C1-C3)alkil olur. Bu bilesikler, CRF reseptörlerine yönelik afinite sergiler.
TR2002/01600T 1999-12-17 2000-12-14 Yer-alıma tabi tutulan, yeni, dallı 3-amino-1-fenil-1H-[1,2,4]triazol amino türevleri, bunların hazırlanması için prosesler ve bunları içeren farmasötik kompozisyonlar. TR200201600T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9915935A FR2802530B1 (fr) 1999-12-17 1999-12-17 Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
TR200201600T2 true TR200201600T2 (tr) 2002-10-21

Family

ID=9553380

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2004/01775T TR200401775T4 (tr) 1999-12-17 2000-12-14 3-Amino-1-Fenil-1H[1,2,4] triazol'ün dallanmış değiştirilmiş yeni amino türevleri, bunların imali için metot ve bunları içeren farmosötik (eczacılık) bileşimleri
TR2002/01600T TR200201600T2 (tr) 1999-12-17 2000-12-14 Yer-alıma tabi tutulan, yeni, dallı 3-amino-1-fenil-1H-[1,2,4]triazol amino türevleri, bunların hazırlanması için prosesler ve bunları içeren farmasötik kompozisyonlar.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2004/01775T TR200401775T4 (tr) 1999-12-17 2000-12-14 3-Amino-1-Fenil-1H[1,2,4] triazol'ün dallanmış değiştirilmiş yeni amino türevleri, bunların imali için metot ve bunları içeren farmosötik (eczacılık) bileşimleri

Country Status (33)

Country Link
US (1) US6806282B2 (tr)
EP (1) EP1242389B1 (tr)
JP (1) JP4146641B2 (tr)
KR (1) KR100705525B1 (tr)
CN (1) CN1293061C (tr)
AR (1) AR031837A1 (tr)
AT (1) ATE264847T1 (tr)
AU (1) AU780711B2 (tr)
BR (1) BR0017023A (tr)
CA (1) CA2398772C (tr)
CO (1) CO5251379A1 (tr)
CZ (1) CZ302460B6 (tr)
DE (1) DE60010126T2 (tr)
DK (1) DK1242389T3 (tr)
EA (1) EA004957B1 (tr)
EE (1) EE04778B1 (tr)
ES (1) ES2219436T3 (tr)
FR (1) FR2802530B1 (tr)
HU (1) HUP0204080A3 (tr)
IL (2) IL150037A0 (tr)
IS (1) IS2315B (tr)
ME (1) MEP12108A (tr)
MX (1) MXPA02006033A (tr)
NO (1) NO20022828L (tr)
PL (1) PL203819B1 (tr)
PT (1) PT1242389E (tr)
RS (1) RS50289B (tr)
SK (1) SK285994B6 (tr)
TR (2) TR200401775T4 (tr)
TW (1) TWI289554B (tr)
UA (1) UA73333C2 (tr)
WO (1) WO2001044207A2 (tr)
ZA (1) ZA200204422B (tr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1663211B1 (en) * 2003-08-06 2010-01-20 Vertex Pharmaceuticals Incorporated Aminotriazole compounds useful as inhibitors of protein kinases
JO3019B1 (ar) 2006-04-19 2016-09-05 Janssen Pharmaceutica Nv ثلاثي مستبدل 4،2،1-ثلاثي زولات
JO2784B1 (en) 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
ES2424023T3 (es) 2007-10-18 2013-09-26 Janssen Pharmaceutica N.V. 1,2,4-triazoles trisustituidos
CA2714662C (en) * 2008-03-19 2016-05-10 Janssen Pharmaceutica Nv Trisubstituted 1,2,4-triazoles as nicotinic acetylcholine receptor modulators
CL2009001125A1 (es) 2008-05-09 2011-02-11 Janssen Pharmaceutica Nv Compuestos derivados de pirazol trisustituido, moduladores alostericos positivos de los receptores ach nicotinicos; composicion farmaceutica que los comprende; proceso de preparacion de la composicion; y su uso en el tratamiento de enfermedades de snc o inflamatorias.
US20130225583A1 (en) * 2010-10-21 2013-08-29 Gerald W. Shipps, Jr. Substituted amino-triazolyl pde10 inhibitors
RU2718918C2 (ru) 2014-01-21 2020-04-15 Ньюрокрайн Байосайенсиз, Инк. Антагонисты рецептора cfr1 для лечения врожденной гиперплазии коры надпочечников
CN104059027B (zh) * 2014-07-01 2015-10-28 河北大学 一类含1,2,4-三唑的(e)-甲氧基亚氨基苯乙酸甲酯类化合物及其制备方法和用途
BR112021010847A2 (pt) 2018-12-07 2021-09-08 Neurocrine Biosciences Inc. Antagonista de receptor de crf1, formulações farmacêuticas e formas sólidas das mesmas para o tratamento de hiperplasia adrenal congênita
TWI849432B (zh) * 2019-09-25 2024-07-21 波蘭商摩爾治療股份公司 製造5-(4-((2s,5s)-5-(4-氯芐基)-2-甲基嗎啉基)哌啶-1-基)-1h-1,2,4-三唑-3-胺的方法
US12383536B2 (en) 2019-09-27 2025-08-12 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3869167D1 (de) * 1987-03-27 1992-04-23 Kumiai Chemical Industry Co Phenyltriazol-derivate und insectizid.
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2763337B1 (fr) * 1997-05-13 1999-08-20 Sanofi Sa Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
DK1242389T3 (da) 2004-08-09
CA2398772A1 (fr) 2001-06-21
SK8502002A3 (en) 2003-02-04
HK1055947A1 (en) 2004-01-30
EE04778B1 (et) 2007-02-15
EA004957B1 (ru) 2004-10-28
KR20020061002A (ko) 2002-07-19
IL150037A0 (en) 2002-12-01
UA73333C2 (en) 2005-07-15
PT1242389E (pt) 2004-08-31
ES2219436T3 (es) 2004-12-01
CO5251379A1 (es) 2003-02-28
SK285994B6 (sk) 2008-01-07
EP1242389A2 (fr) 2002-09-25
IL150037A (en) 2007-02-11
EP1242389B1 (fr) 2004-04-21
DE60010126T2 (de) 2005-04-28
TR200401775T4 (tr) 2004-09-21
ATE264847T1 (de) 2004-05-15
CZ302460B6 (cs) 2011-06-01
IS6402A (is) 2002-05-28
EA200200523A1 (ru) 2002-12-26
FR2802530B1 (fr) 2002-02-22
PL355811A1 (en) 2004-05-17
WO2001044207A8 (fr) 2001-07-12
NO20022828D0 (no) 2002-06-13
NO20022828L (no) 2002-08-19
JP4146641B2 (ja) 2008-09-10
WO2001044207B1 (fr) 2002-06-06
JP2003516975A (ja) 2003-05-20
TWI289554B (en) 2007-11-11
HUP0204080A2 (hu) 2003-04-28
FR2802530A1 (fr) 2001-06-22
EE200200331A (et) 2003-06-16
WO2001044207A2 (fr) 2001-06-21
HUP0204080A3 (en) 2005-01-28
WO2001044207A3 (fr) 2001-12-20
CN1293061C (zh) 2007-01-03
AU780711B2 (en) 2005-04-14
BR0017023A (pt) 2002-12-03
US20030162771A1 (en) 2003-08-28
MXPA02006033A (es) 2003-01-28
US6806282B2 (en) 2004-10-19
YU43902A (sh) 2005-03-15
PL203819B1 (pl) 2009-11-30
AR031837A1 (es) 2003-10-08
DE60010126D1 (de) 2004-05-27
CA2398772C (fr) 2011-07-05
MEP12108A (en) 2010-06-10
IS2315B (is) 2007-11-15
ZA200204422B (en) 2003-11-26
KR100705525B1 (ko) 2007-04-10
RS50289B (sr) 2009-09-08
CN1434808A (zh) 2003-08-06
AU2525901A (en) 2001-06-25
CZ20022099A3 (cs) 2002-09-11

Similar Documents

Publication Publication Date Title
DE602004032431D1 (de) Pyrimidin-verbindungen und diese enthaltende zusammensetzungen zur schädlingsbekämpfung
EA200601847A1 (ru) Замещённые метиларил- или гетероариламидные соединения
RO96802B (ro) Compozitie erbicida lichida
FR2842804B1 (fr) Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
TR200201600T2 (tr) Yer-alıma tabi tutulan, yeni, dallı 3-amino-1-fenil-1H-[1,2,4]triazol amino türevleri, bunların hazırlanması için prosesler ve bunları içeren farmasötik kompozisyonlar.
AU3599701A (en) Fluorescent probes for the quantitation of zinc
BR9510006A (pt) Derivados de anilina possuindo efeito inibidor de sintase do óxido nítrico
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
CY1113359T1 (el) Αντι-νεοπλασιακα παραγωγα του et-743
ES2081136T3 (es) 3-ureido-benzodiazepinonas utiles como antagonistas de cck o de gastrina.
ATE503746T1 (de) Neue imidazolidinderivate
DK1447400T3 (da) Bicyklisk forbindelse
ATE550332T1 (de) 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors
FI971227A0 (fi) Pyramidinyylipyratsolijohdannaisia
ATE504583T1 (de) 4-imidazolin-2-onverbindungen
ATE367377T1 (de) Bis(5-aryl-2-pyridyl)derivate
BR9812928A (pt) Novos derivados de 3-oxo-(2h) -1,2,4-triazina, processo de preparação de compostos quìmicos, e, composição farmacêutica
TW200510300A (en) Amino alcohol compounds
NO20004477L (no) Anvendelse av organiske karbonater for vasking av metalloverflater
TW200626007A (en) Material for electroluminescent element and electroluminescent element
GB0427491D0 (en) Process and compounds
UA39157C2 (uk) Спосіб одержання похідних 2-арил-3-метил-4-оксо-3,4-дигідрохіназоліну та похідні 7-азабензонорборнену як проміжні сполуки
TH45771A (th) อนุพันธ์ไฮดราโซนและสารควบคุมสิ่งมีชีวิตที่เป็นอันตราย